Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$197.11 - $250.07 $26,609 - $33,759
-135 Reduced 4.47%
2,884 $628,000
Q3 2022

Nov 14, 2022

BUY
$182.44 - $250.54 $12,953 - $17,788
71 Added 2.41%
3,019 $594,000
Q2 2022

Aug 15, 2022

SELL
$204.13 - $302.4 $20.8 Million - $30.9 Million
-102,138 Reduced 97.19%
2,948 $631,000
Q1 2022

May 16, 2022

BUY
$255.51 - $362.11 $11.8 Million - $16.7 Million
45,994 Added 77.83%
105,086 $29.8 Million
Q4 2021

Feb 14, 2022

SELL
$351.38 - $448.68 $8.9 Million - $11.4 Million
-25,334 Reduced 30.01%
59,092 $22.3 Million
Q3 2021

Nov 15, 2021

SELL
$372.64 - $458.3 $2.36 Million - $2.91 Million
-6,342 Reduced 6.99%
84,426 $34.8 Million
Q2 2021

Aug 02, 2021

SELL
$294.17 - $371.65 $4.87 Million - $6.16 Million
-16,563 Reduced 15.43%
90,768 $33.6 Million
Q1 2021

May 17, 2021

SELL
$249.67 - $299.48 $2.87 Million - $3.44 Million
-11,502 Reduced 9.68%
107,331 $31.1 Million
Q4 2020

Jan 26, 2021

SELL
$222.0 - $252.62 $1.28 Million - $1.46 Million
-5,777 Reduced 4.64%
118,833 $29.7 Million
Q3 2020

Nov 12, 2020

BUY
$175.56 - $226.45 $1.04 Million - $1.34 Million
5,921 Added 4.99%
124,610 $28.2 Million
Q2 2020

Aug 14, 2020

SELL
$118.84 - $189.72 $8.27 Million - $13.2 Million
-69,611 Reduced 36.97%
118,689 $20.7 Million
Q1 2020

May 15, 2020

SELL
$98.9 - $178.34 $105,625 - $190,467
-1,068 Reduced 0.56%
188,300 $23.8 Million
Q4 2019

Jan 27, 2020

BUY
$126.05 - $152.76 $35,294 - $42,772
280 Added 0.15%
189,368 $28.9 Million
Q3 2019

Nov 06, 2019

BUY
$125.07 - $143.67 $6.07 Million - $6.97 Million
48,494 Added 34.49%
189,088 $25 Million
Q2 2019

Jul 12, 2019

BUY
$123.4 - $148.55 $417,955 - $503,138
3,387 Added 2.47%
140,594 $20 Million
Q1 2019

May 08, 2019

BUY
$104.82 - $146.73 $417,078 - $583,838
3,979 Added 2.99%
137,207 $19.9 Million
Q4 2018

Feb 14, 2019

SELL
$105.09 - $137.23 $2.02 Million - $2.64 Million
-19,252 Reduced 12.63%
133,228 $15.1 Million
Q3 2018

May 08, 2019

SELL
$112.11 - $134.54 $4,260 - $5,112
-38 Reduced 0.02%
152,480 $20.5 Million
Q3 2018

Nov 14, 2018

BUY
$112.11 - $134.54 $1.03 Million - $1.23 Million
9,161 Added 6.39%
152,518 $20.5 Million
Q2 2018

Aug 14, 2018

BUY
$102.37 - $117.25 $14 Million - $16 Million
136,820 Added 2093.01%
143,357 $16.1 Million
Q1 2018

May 08, 2019

SELL
$98.19 - $115.2 $149,052 - $174,873
-1,518 Reduced 18.85%
6,537 $698,000
Q1 2018

May 15, 2018

BUY
$98.19 - $115.2 $51,746 - $60,710
527 Added 7.0%
8,055 $860,000
Q4 2017

Feb 14, 2018

BUY
$100.43 - $118.09 $6,929 - $8,148
69 Added 0.93%
7,528 $824,000
Q3 2017

Nov 14, 2017

BUY
$96.72 - $109.26 $721,434 - $814,970
7,459
7,459 $806,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.56B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Clark Capital Management Group, Inc. Portfolio

Follow Clark Capital Management Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clark Capital Management Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Clark Capital Management Group, Inc. with notifications on news.